BPI 2026: Panel addresses cost challenges at BioProcess International event in Boston
BioProcess International kicked off its namesake and flagship event yesterday in Boston, Massachusetts, with a series of educational talks and...
How We Can Collectively Accelerate Digital Transformation in Biomanufacturing: Scalable Adoption Frameworks Discussed During Roundtable 5 of the 2025 BioInnovation Group Executive Summit
Digital transformation in the biopharmaceutical industry is widely acknowledged as an essential step, but progress remains uneven, fragmented,...
Decentralized Apheresis: The Missing Link in Equitable Cell and Gene Therapy Access?
Cell and gene therapies (CGTs) promise to transform medicine, offering potential cures for diseases that were previously untreatable. Although...
Making more than chocolate: Swiss CDMO gets go-ahead to make siRNAs
Earlier this month, Swiss-based contract development and manufacturing organization (CDMO) ten23 health announced GMP certification to...
FDA committee approves loosening peptide regulation despite own evidence
Last week, the US Food and Drug Administration (FDA) held a two-day advisory committee meeting concerning popular “gray market” peptides. The...
More From BioProcess Insider
Pfizer will produce its COVID-19 vaccine from its Grange Castle facility in Dublin, as part of a $40 million investment. The firm’s partnership...
Thermo teams with UCSF on San Fran cell therapy center
Thermo Fisher Scientific has teamed up with the University of California, San Francisco (UCSF) to set up a cell therapy manufacturing...
Pfizer invests $40m to manufacture COVID-19 vaccine in Ireland
Pfizer will produce its COVID-19 vaccine from its Grange Castle facility in Dublin, as part of a $40 million investment.
The firm’s partnership...



